Works matching IS 2234-943X AND VI 12 AND DT 2022

Results: 5000

Editorial: Prognosis prediction and risk stratification in head and neck cancer .

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1037001

By:

Tengxiang Li;
Jie Lu;
Yong Yin;
Qingtao Qiu

Publication type:

Article

Highly sensitive liquid biopsy Duplex sequencing complements tissue biopsy to enhance detection of clinically relevant genetic variants.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1014592

By:

Hallermayr, Ariane;
Neuhann, Teresa M.;
Steinke-Lange, Verena;
Scharf, Florentine;
Laner, Andreas;
Ewald, Roland;
Liesfeld, Ben;
Holinski-Feder, Elke;
Pickl, Julia M. A.

Publication type:

Article

Editorial: Therapies and influences in urothelial carcinoma.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1126494

By:

Ozgun, G.;
Isharwal, S.;
Eigl, B. J.

Publication type:

Article

Editorial: Molecular characteristics and personalized treatment for pediatric brain tumors.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1114280

By:

Weijun Feng;
Daisuke Kawauchi;
Feng Wan

Publication type:

Article

Higher radiation doses after partial laryngectomy may raise the incidence of pneumonia: A retrospective cohort study.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1072474

By:

Guoqi Lv;
Xiuling Wu;
Zhengying Wang;
Kanglong Wu;
Geer Ang;
Shulin Cui;
Yuqi Shi;
Yu Wang;
Delong Liu

Publication type:

Article

Frizzled receptors in melanomagenesis: From molecular interactions to target identification.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1096134

By:

Umar, Sheikh A.;
Bo Dong;
Nihal, Minakshi;
Hao Chang

Publication type:

Article

Case report: <sup>18</sup>F-FES PET/CT predicted treatment responses of second-line and third-line CDK4/6 inhibitors after disease progression on first-line CDK4/6 inhibitor in a HR+/HER2-metastatic breast cancer patient.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1095779

By:

Bo Pan;
Zhixin Hao;
Ying Xu;
Zhe Wang;
Ru Yao;
Xuefei Wang;
Chao Ren;
Yidong Zhou;
Qiang Sun;
Li Huo

Publication type:

Article

Editorial: Awake surgery for brain tumors and brain connectomics.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1094818

By:

Montemurro, Nicola;
Trevisi, Gianluca

Publication type:

Article

Minor histological components predict the recurrence of patients with resected stage I acinar- or papillary-predominant lung adenocarcinoma.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1090544

By:

Wei Liu;
Qian Zhang;
Tiantian Zhang;
Li Li;
Chunhua Xu

Publication type:

Article

Advances in peptides encoded by non-coding RNAs: A cargo in exosome.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1081997

By:

Jing Yang;
Mengxiao Liu;
Xidong Fang;
Huiyun Zhang;
Qian Ren;
Ya Zheng;
Yuping Wang;
Yongning Zhou

Publication type:

Article

Comprehensive analysis of the significance of METTL7A gene in the prognosis of lung adenocarcinoma.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1071100

By:

Ya-Qiang Pan;
Ying Xiao;
Zhenhua Li;
Long Tao;
Ge Chen;
Jing-Feng Zhu;
Lu Lv;
Jian-Chao Liu;
Jun-Qing Qi;
AiZhong Shao

Publication type:

Article

What is the future of treatment de-escalation for HPV-positive oropharyngeal cancer? A review of ongoing clinical trials.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1067321

By:

Mensour, Emma A.;
Alam, Shintha;
Mawani, Seliya;
Bahig, Houda;
Lang, Pencilla;
Nichols, Anthony;
Palma, David A.;
Jasper, Katie

Publication type:

Article

Comparison of chemotherapy regimens plus rituximab in adult Burkitt lymphoma: A single-arm meta-analysis.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1063689

By:

Xiaoxuan Lu;
Yu Liu;
Ruyu Liu;
Jiaxin Liu;
Xiaojing Yan;
Liren Qian

Publication type:

Article

Case report: Gemcitabine intravesical hyperthermic infusion combined with tislelizumab in muscle invasive bladder urothelium carcinoma.

Published in:

2022

By:

Zheng Du;
Huaqi Yin;
Shiming Zhao;
Yongkang Ma;
Zhenghui Sun;
Bingqi Dong;
Mingkai Zhu;
Chaoshuai Zhu;
Jiangshan Peng;
Tiejun Yang

Publication type:

Case Study

Prognostic significance of steroid response in pediatric acute lymphoblastic leukemia: The CCCG-ALL-2015 study.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1062065

By:

Jinhua Chu;
Huaju Cai;
Jiaoyang Cai;
Xinni Bian;
Yumei Cheng;
Xianmin Guan;
Xiaoqian Chen;
Hua Jiang;
Xiaowen Zhai;
Yongjun Fang;
Lei Zhang;
Xin Tian;
Fen Zhou;
Yaqin Wang;
Lingzhen Wang;
Hong Li;
Alex, Leung Wing Kwan;
Minghua Yang;
Hanfang Yang;
Aijun Zhan

Publication type:

Article

Overexpression of Mena is associated with tumor progression and poor prognosis in oral squamous cell carcinoma via EMT.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1052375

By:

Sijia Na;
Hao Cui;
Zhichen Guo;
Xiang Liang;
Sakran, Karim Ahmed;
Xiaomei Guo;
Xingqiang Li;
Linyang Xie;
Yifei Zhu;
Hong Qi;
Junbo Tu

Publication type:

Article

Detecting plasma hsa_circ_0061276 in patients with gastric cancer by reverse transcription-digital polymerase chain reaction.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1042248

By:

Yao Ruan;
Zhe Li;
Yaoyao Xie;
Weiliang Sun;
Junming Guo

Publication type:

Article

Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1041443

By:

Olgun, Nur;
Cecen, Emre;
Ince, Dilek;
Kizmazoglu, Deniz;
Baysal, Birsen;
Onal, Ayse;
Ozdogan, Ozhan;
Guleryuz, Handan;
Cetingoz, Riza;
Demiral, Ayse;
Olguner, Mustafa;
Celik, Ahmet;
Kamer, Serra;
Ozer, Erdener;
Altun, Zekiye;
Aktas, Safiye

Publication type:

Article

Abdominoinguinal approach in en bloc resection of retroperitoneal sarcoma involving iliac vessels with graft interposition.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1040833

By:

Ang Lv;
Bo-Nan Liu;
Dao-Ning Liu;
Zhen Wang;
Chun-Yi Hao

Publication type:

Article

Successful treatment of extensive-stage small cell lung cancer with concurrent pleural and pericardial effusions: Case report.

Published in:

2022

By:

Ayaka Kashima;
Yosuke Fukuda;
Miri Shimamura;
Miharu Ijichi;
Hironori Sagara

Publication type:

Case Study

Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1037742

By:

Lanjuan Li;
Fengmin Lu;
Ping Chen;
Haolin Song;
Wei Xu;
Jin Guo;
Jianfei Wang;
Juhong Zhou;
Xiang Kang;
Chaolei Jin;
Yubo Cai;
Zixuan Feng;
Hainv Gao

Publication type:

Article

Association of baseline self-reported fatigue with overall survival after stereotactic body radiation therapy for localized prostate cancer.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1015264

By:

Simhal, Rishabh K.;
Sholklapper, Tamir N.;
Simhal, Anish K.;
Zwart, Alan L.;
Danner, Malika T.;
Kumar, Deepak;
Aghdam, Nima;
Suy, Simeng;
Hankins, Ryan A.;
Kowalczyk, Keith J.;
Collins, Sean P.

Publication type:

Article

Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.992455

By:

Haque, Emaan;
Muhsen, Ibrahim N.;
Esmail, Abdullah;
Umoru, Godsfavour;
Mylavarapu, Charisma;
Ajewole, Veronica B.;
Abdelrahim, Maen

Publication type:

Article

Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.977664

By:

Padmanabhan, Regina;
Kheraldine, Hadeel;
Gupta, Ishita;
Meskin, Nader;
Hamad, Anas;
Vranic, Semir;
Al Moustafa, Ala-Eddin

Publication type:

Article

Treatment strategies for hormone receptor-positive, human epidermal growth factor receptor 2-positive (HR+/HER2+) metastatic breast cancer: A review.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.975463

By:

Ran Ran;
Yingying Ma;
Hui Wang;
Jin Yang;
Jiao Yang

Publication type:

Article

Endoscopic endonasal resection of an epidermoid cyst in the cavernous sinus: A case report and literature review.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.972573

By:

Yinzi Wu;
Zhimin Li;
Jun Gao;
Yong Yao;
Renzhi Wang;
Xinjie Bao

Publication type:

Article

Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.972322

By:

Patil, Darshana;
Akolkar, Dadasaheb;
Nagarkar, Rajnish;
Srivastava, Navin;
Datta, Vineet;
Patil, Sanket;
Apurwa, Sachin;
Srinivasan, Ajay;
Datar, Rajan

Publication type:

Article

A pyroptosis-related gene signature for prognostic and immunological evaluation in breast cancer.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.964508

By:

Yue Zhong;
Fu Peng;
Xiaoru Luo;
Xuan Wang;
Bowen Yang;
Xinglinzi Tang;
Zheng Xu;
Linlin Ren;
Zhiyu Wang;
Cheng Peng;
Neng Wang

Publication type:

Article

The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.956706

By:

Jun-Bing Chen;
Zi-Ning Liu;
Yin-Kui Wang;
Fei Shan;
Shuang-Xi Li;
Yong-Ning Jia;
Kan Xue;
Ru-Lin Miao;
Zhe-Min Li;
Zhou-Qiao Wu;
Xiang-Ji Ying;
Yan Zhang;
Zi-Yu Li;
Jia-Fu Ji

Publication type:

Article

Preclinical profiles of SKB264, a novel anti-TROP2 antibody conjugated to topoisomerase inhibitor, demonstrated promising antitumor efficacy compared to IMMU-132.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.951589

By:

Yezhe Cheng;
Xiaoxi Yuan;
Qiang Tian;
Xiuying Huang;
Yang Chen;
Yuzhi Pu;
Hu Long;
Mingyu Xu;
Yafei Ji;
Jia Xie;
Yuping Tan;
Xi Zhao;
Hongmei Song

Publication type:

Article

Editorial: Advances in radiotherapy for prostate cancer.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1122652

By:

Kamran, Sophia C.;
Kerkmeijer, Linda G. W.;
Zamboglou, Constantinos

Publication type:

Article

Editorial: Biological aspects of targeted drug discovery: Development of novel targets and/or chemotherapies, and drug repurposing.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1106610

By:

Kalra, Rajkumar Singh;
Singh, Sandeep;
Munshi, Anjana;
Bariwal, Jitender

Publication type:

Article

Editorial: Reviews in hematologic malignancies.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1105523

By:

Saraceni, Francesco;
Morè, Sonia

Publication type:

Article

Neutrophil extracellular traps-associated modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of clear cell renal cell carcinoma.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1094248

By:

Zhi-Hai Teng;
Wen-Ce Li;
Zhi-Chao Li;
Ya-Xuan Wang;
Zhen-Wei Han;
Yan-Ping Zhang

Publication type:

Article

Editorial: Ion channels & homeostasis of ions in cancer cell fate.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1090583

By:

Wei Cheng;
Linlin Ma;
Zui Pan

Publication type:

Article

Cancer diagnosis in areas of conflict.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1087476

By:

Al-Ibraheem, Akram;
Abdlkadir, Ahmed Saad;
Mohamedkhair, Ali;
Mikhail-Lette, Miriam;
Al-Qudah, Mohammad;
Paez, Diana;
Mansour, Asem H.

Publication type:

Article

Totally laparoscopic total gastrectomy with Uncut Roux-en-Y for gastric cancer may improve prognosis: A propensity score matching comparative study.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1086966

By:

Yizhen Chen;
Tao Zheng;
Yifan Chen;
Yuanyuan Zheng;
Song Tan;
Shaolin Liu;
Yuhang Zhou;
Xiaojun Lin;
Weijie Chen;
Yulong Mi;
Shentao Lin;
Changshun Yang;
Weihua Li

Publication type:

Article

Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1081091

By:

Wenhao Wang;
Shan Hua;
Jianying Li;
Jing Zhao;
Yu Zhang;
Juntao Jiang;
Bangmin Han

Publication type:

Article

Comprehensive analysis of cuproptosis-related long non-coding RNA signature and personalized therapeutic strategy of breast cancer patients.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1081089

By:

Qiaonan Guo;
Pengjun Qiu;
Kelun Pan;
Jianqing Lin

Publication type:

Article

Identifying diagnostic markers and constructing a prognostic model for small-cell lung cancer based on blood exosome-related genes and machine-learning methods.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1077118

By:

Kun Zhang;
Chaoguo Zhang;
Ke Wang;
Xiuli Teng;
Mingwei Chen

Publication type:

Article

The potential value of LC-MS non-targeted metabonomics in the diagnosis of follicular thyroid carcinoma.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1076548

By:

Jiali Qin;
Yang Yang;
Wei Du;
Gang Li;
Yao Wu;
Ruihua Luo;
Shanting Liu;
Jie Fan

Publication type:

Article

Knowledge mapping visualization of the pulmonary ground-glass opacity published in the web of science.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1075350

By:

Xingchen Li;
Guochao Zhang;
Shugeng Gao;
Qi Xue;
Jie He

Publication type:

Article

Case report: Rare intrapulmonary malignant mesothelioma complicated with myositis.

Published in:

2022

By:

Dandan Gong;
Jian Yu;
Xiaodong Jiang

Publication type:

Case Study

Soluble HLA peptidome: A new resource for cancer biomarkers.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1069635

By:

Tanuwidjaya, Erwin;
Schittenhelm, Ralf B.;
Faridi, Pouya

Publication type:

Article

Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1068981

By:

Maitre, Elsa;
Paillassa, Jerome;
Troussard, Xavier

Publication type:

Article

Short-term outcomes of deeper intubation technique of ileus tube for different types of acute intestinal obstruction patients: A retrospective multicenter study.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1065692

By:

Yanlu Tan;
Fangxu Yin;
Zhihua Lu;
Peng Huang;
Chengcai Zhang;
Jiuzheng Sun;
Song Wang;
Zhensheng Dong

Publication type:

Article

Case Report: Toxic epidermal necrolysis associated with sintilimab in a patient with relapsed thymic carcinoma.

Published in:

2022

By:

Huayu Yang;
Qing Ma;
Ying Sun;
Kan Zhang;
Yunli Xing;
Hongwei Li

Publication type:

Case Study

Tailoring the clinical management of colorectal cancer by <sup>18</sup>F-FDG PET/CT.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1062704

By:

Yang Shi;
Meiqi Wang;
Jiyu Zhang;
Zheng Xiang;
Can Li;
Jingjing Zhang;
Xing Ma

Publication type:

Article

PLK4 initiates crosstalk between cell cycle, cell proliferation and macrophages infiltration in gliomas.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1055371

By:

Xiaoyang Zhang;
Zesheng Li;
Cheng Wei;
Lin Luo;
Shenghui Li;
Junhu Zhou;
Hao Liang;
Ying Li;
Lei Han

Publication type:

Article

Case Report: Stage IIIc primary malignant mixed Müllerian tumor of the fallopian tube: A case of 5-year disease-free survival after cytoreductive surgery combined with peritoneal resection and adjuvant chemotherapy with paclitaxel plus carboplatin.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1054307

By:

Xiaoli Xiao;
Ruiqing Ma;
Lianyao Shi;
Cong Wang;
Jie Chen;
Yiyan Lu;
Yufeng Wang;
Xichao Zhai;
Fengxian Fu

Publication type:

Article